Keith A Greathouse

President & CEO at DermAvance Pharmaceuticals

Keith A. Greathouse has over 35 years of industry experience with major pharmaceutical companies. Prior to founding DermAvance, Mr. Greathouse served as executive vice president for Sanofi-Aventis Dermatology (Dermik), where he launched many significant new dermatology products such as Benzamycin, Benzaclin, Carac, Penlac, Klaron, Psorcon, Noritate, Vanamide, and most recently, Sculptra. He has a Bachelor of Arts degree in Marketing from San Jose State University and a Doctorate from New York College of Podiatric Medicine. He currently serves on the boards of the Women’s Dermatologic Foundation and is a trustee and secretary for the Board of Trustees of the New York College of Podiatric Medicine. Mr. Greathouse is active in the following societies: the American Academy Of Dermatology (AAD), the American Society of Dermatologic Surgeons, (ASDS), The Skin Cancer Foundation (SCF), American Academy of Plastic Surgery (AAPS).

Links


Org chart

Sign up to view 1 direct report

Get started